Cahill represented the underwriters in connection with a public offering of $600,000,000 aggregate principal amount of 4.300% senior notes due 2028 by Edwards Lifesciences Corporation. Edwards…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
